Literature DB >> 15760618

Survival following dementia onset: Alzheimer's disease and vascular dementia.

Annette L Fitzpatrick1, Lewis H Kuller, Oscar L Lopez, Claudia H Kawas, William Jagust.   

Abstract

Survival following the onset of dementia has been reported to vary from 3 to over 9 years. We examined mortality in 3602 participants of the Cardiovascular Health (CHS) Cognition Study in four US communities evaluated for dementia incidence between 1992 and 1999 and followed for 6.5 years. By June 2000, 33 of 62 (53.2%) participants who developed vascular dementia (VaD) had died compared to 79 of 245 (32.2%) with Alzheimer's disease (AD), 66 of 151 (43.7%) with both AD and VaD, and 429 of 2318 (18.5%) with normal cognition. Using Cox proportional hazards regression with a time-dependent covariate for dementia status adjusted for age, gender and race, individuals with VaD were more than four times as likely to die during follow-up than those with normal cognition (HR: 4.4, 95% CI: 3.1-6.3). The hazard ratios were 2.1 (95% CI: 1.6-2.7) for AD and 2.5 (95% CI: 1.9-3.3) for both types. Adjusted accelerated life models estimated median survival from dementia onset to death as 3.9 years for those with VaD, 7.1 years for AD, 5.4 years for mixed dementia, and 11.0 years for matched controls with normal cognition. While persons with VaD died primarily from cerebrovascular disease, those with AD/mixed dementia died more frequently from dementia/failure to thrive.

Entities:  

Mesh:

Year:  2004        PMID: 15760618     DOI: 10.1016/j.jns.2004.11.022

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  48 in total

1.  Voxel Level Survival Analysis of Grey Matter Volume and Incident Mild Cognitive Impairment or Alzheimer's Disease.

Authors:  Lubov E Zeifman; William F Eddy; Oscar L Lopez; Lewis H Kuller; Cyrus Raji; Paul M Thompson; James T Becker
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

2.  Long-term cost-effectiveness of donepezil for the treatment of Alzheimer's disease.

Authors:  Stefan J Teipel; Michael Ewers; Veronika Reisig; Bernd Schweikert; Harald Hampel; Michael Happich
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-04-01       Impact factor: 5.270

3.  Primary Caregivers in a Network Context.

Authors:  Christopher Steven Marcum; Sato Ashida; Laura M Koehly
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2020-01-01       Impact factor: 4.077

Review 4.  Vascular cognitive impairment: disease mechanisms and therapeutic implications.

Authors:  Deborah A Levine; Kenneth M Langa
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

Review 5.  Dementia and co-occurring chronic conditions: a systematic literature review to identify what is known and where are the gaps in the evidence?

Authors:  Mark B Snowden; Lesley E Steinman; Lucinda L Bryant; Monique M Cherrier; Kurt J Greenlund; Katherine H Leith; Cari Levy; Rebecca G Logsdon; Catherine Copeland; Mia Vogel; Lynda A Anderson; David C Atkins; Janice F Bell; Annette L Fitzpatrick
Journal:  Int J Geriatr Psychiatry       Date:  2017-02-01       Impact factor: 3.485

6.  Negative Conditioning of Mitochondrial Dysfunction in Age-related Neurodegenerative Diseases.

Authors:  Sharmelee Selvaraji; Luting Poh; Venkateswaran Natarajan; Karthik Mallilankaraman; Thiruma V Arumugam
Journal:  Cond Med       Date:  2019-02

7.  Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease.

Authors:  O L Lopez; J T Becker; A S Wahed; J Saxton; R A Sweet; D A Wolk; W Klunk; S T Dekosky
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-02-09       Impact factor: 10.154

8.  [Impact of vascular pathology on survival times of 173 dementia patients--Hachinski's ischemic score as a predictive tool for clinical purposes].

Authors:  S Kissler; S D Hötte; D Lankers; G Juckel; S G Schröder
Journal:  Z Gerontol Geriatr       Date:  2008-02       Impact factor: 1.281

9.  Race/ethnic differences in AD survival in US Alzheimer's Disease Centers.

Authors:  K M Mehta; K Yaffe; E J Pérez-Stable; A Stewart; D Barnes; B F Kurland; B L Miller
Journal:  Neurology       Date:  2007-11-14       Impact factor: 9.910

Review 10.  Vascular dementia: prevention and treatment.

Authors:  Catherine McVeigh; Peter Passmore
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.